Harvia Oyj
Harvia will publish its Interim Report for January−March 2025 on Wednesday, 7 May 2025 at around 9:00 a.m. EEST
Harvia will publish its Interim Report for January−March 2025 on Wednesday, 7 May 2025 at around 9:00 a.m. EEST
Harvia Plc press release 30 April 2025 at 9:00 a.m. EEST
Harvia will publish its Interim Report for the period of January−March 2025 on Wednesday, 7 May 2025 at around 09:00 a.m. Finnish time. The stock exchange release and the presentation material will be available after publishing at https://harviagroup.com/investor-relations/.
Harvia will hold a webcast for analysts, investors and media on 7 May 2025 at 11:00 a.m. EEST. The conference will be held in English. Harvia’s CEO Matias Järnefelt and CFO Ari Vesterinen will host the event. The webcast can be followed at https://harvia.events.inderes.com/q1-2025.
A recording of the webcast will be available after the event on the company’s website https://harviagroup.com/investor-relations/.
HARVIA PLC
For further information, please contact:
CFO Ari Vesterinen, ari.vesterinen@harvia.com, tel. +358 40 5050 440
Harvia is one of the leading companies operating in the sauna market globally, as measured by revenue. Harvia’s brands and product portfolio are well known in the market, and the company’s comprehensive product portfolio strives to meet the needs of the international sauna market of both private and professional customers.
Harvia’s revenue totaled EUR 175.2 million in 2024. Harvia Group employs approximately 700 professionals in Finland, United States, Germany, Romania, China and Hong Kong, Austria, Italy, Estonia, and Sweden. The company is headquartered in Muurame, Finland, adjacent to its largest sauna and sauna component manufacturing facility.
Read more: https://harviagroup.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Genmab A/S15.6.2025 11:00:00 CEST | Press release
Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)
F. Hoffmann-La Roche Ltd15.6.2025 07:00:00 CEST | Press release
[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys™ gene therapy for Duchenne muscular dystrophy in non-ambulatory patients
Hotel Belles Rives15.6.2025 01:34:58 CEST | Press release
Prix Fitzgerald 2025 Laureate Announced at Hôtel Belles Rives
KOORUI14.6.2025 11:56:35 CEST | Press release
KOORUI Launches 34-Inch Curved Monitor 34E6UC Globally, Empowering Hybrid Work and Immersive Entertainment
Atico Mining Corporation14.6.2025 00:30:30 CEST | Press release
Atico Mining Files Amended and Restated Rights Offering Circular and LIFE Offering Document
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom